Navigation Links
Periods in Biological Technology

GenVec Reports Second Quarter 2009 Financial Results

... Revenues for the three-month and six-month periods ended June 30, 2009 were $3.8 million and $7.6 ... year periods. For the three-month and six-month periods ended June 30, 2009 we experienced decreases in ... to the scope of work performed in the current periods as compared to the prior year. Also contributing ...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... TAXUS may have stabilized after several quarterly periods of significant decline. Royalty revenue for the ... device from patients more easily, or after longer periods of time have passed as compared to existing ... interim financial statements for the three-month periods ended June 30, 2009, and 2008. Full unaudited ...

Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

... The per share amount for the three and six month periods of 2009 includes the effect of the issuance of ... The per share amounts for three and six month periods of 2008 include only the effect of the 2008 ... share amounts between the 2009 and 2008 periods presented. ...

CuraGen Reports Second Quarter 2009 Financial Results

... approval. During the three and six month periods ended June 30, 2009, CuraGen utilized $3.8 ... and $0.7 million for the three and six month periods ended June 30, 2009, respectively. As of June ... and $1.6 million for the three and six month periods ended June 30, 2009, respectively. CuraGen ...

Sunesis Reports Financial Results for the Second Quarter 2009

... to $2.6 million and $4.9 million for the same periods in 2008. Sunesis recognized $2.0 million in the ... milestone referred to above. Revenues in the 2008 periods were primarily related to research funding under ... from $8.3 million and $17.0 million for the same periods in 2008. The decreases were primarily due to ...

Vasogen Announces Second Quarter 2009 Results

... with $7.6 million and $11.0 million for the same periods in 2008. The $1.4 million of net cash used in ... 2009 has decreased when compared with the same periods in 2008 due to the significant expenditures that were incurred during the 2008 periods to implement the restructuring that was announced ...

Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update

... RESULTS FROM OPERATIONS Three and nine month periods ended April 30, 2009 compared to the same period ... respectively, for the three and nine month periods ended April 30, 2009, for a loss per common share ... In the comparative three and nine month periods ended April 30, 2008, the Company recorded a loss ...

Publication of Shire plc's Annual Report 2008

... Rules which applies in respect of accounting periods commencing after January 20, 2007, Appendix to ... distraction of senior management for prolonged periods of time, significant defense costs and ... its key scientific and management personnel for periods of one year or less. The loss of such personnel, ...

Helix BioPharma Announces Q2 2009 Financial Results

... Results from Operations Three and six month periods ended January 31, 2009 compared to the same periods in the previous year Loss for the period ... respectively, for the three and six month periods ended January 31, 2009, for a loss per common ...

OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009

... $4.1 million, respectively, in the corresponding periods of 2007. The increases in 2008 were primarily due ... $3.5 million, respectively, in the corresponding periods of 2007. The increase for the fourth quarter of ... $11.5 million, respectively, in the corresponding periods of 2007. The increase for the fourth quarter of ...

ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results

... Operating income decreased in both comparative periods primarily due to increased amortization expense, ... 14.0 percent, respectively, compared to the same periods in 2007. The cost of sales for the three ... consistent, respectively, as compared to the same periods in 2007. For the three months and year ended ...

Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals

... to estimate the costs to be incurred in those periods and believes those costs do not reflect the ... of ongoing operating results against prior periods and against our internally developed targets. We ... to estimate the costs to be incurred in those periods and believes those costs do not reflect the ...

Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results

... for the same period in 2007. The decrease in both periods primarily reflects revenues from Amgen related to ... the for same period in 2007. The increase in both periods is due primarily to increased costs associated ... were $2.3 million for both of the three-month periods ended September 30, 2008 and 2007. For the nine ...

Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year

... been presented as discontinued operations for all periods presented in the Condensed ... Quarterly periods 4Q08 ... Quarterly periods ...

Oncothyreon reports third quarter 2008 financial results

... and $4.0 million for the three and nine month periods ended September 30, 2008, compared to $1.1 million and $1.9 million for the comparable periods in 2007. The increase in total revenue for the ... per basic and diluted share, for the comparable periods in 2007. Expenses for the three and nine ...

ev3 Inc. Reports Third Quarter 2008 Financial Results

... comparable U.S. GAAP measures for the respective periods can be found immediately following the detail of ... comparable U.S. GAAP measures for the respective periods can be found in tables later in this release ... comparable U.S. GAAP measures for the respective periods can be found in the tables below. In addition, an ...

Thoratec Reports 44 Percent Increase in Third Quarter Revenues

... facilitate comparisons of results for current periods and guidance for future periods with our historical operating results, and assist ... income statement for the three and nine month periods ending 2008 and 2007. ...

VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007

... in the second quarter of 2008 related to periods prior to 2008. VNUS' balance sheet at September ... in the second quarter of 2008 related to periods prior to 2008. VNUS believes Adjusted EBITDA and ... $(6,464) Calculation of Fully Taxed EPS for periods with net income: Income before provision for ...

Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009

... million, respectively, for the corresponding periods of Fiscal 2008. This represents increases of 195% and 200% over the respective periods of Fiscal 2008. Pre-tax income grew to $12.3 ... million, respectively, for the corresponding periods of Fiscal 2008, reflecting increases of 22% and ...

Neuralstem Reports Second Quarter Financial Results and Highlights

... or $(0.10) per share, for the comparable periods in 2007. The increase in net loss year to year ... and development expenses for the six month periods ending June 30, 2008 and 2007 were $2,832,572 and ... and administrative expenses for the six month periods ending June 30, 2008 and 2007 were $2,401,877 and ...

Genaera Corporation Announces Second Quarter Financial Results

... financial results for the three- and six-month periods ended June 30, 2008. The net loss for ... development expenses for the three- and six-month periods ended June 30, 2008 were $3.5 million and $7.4 ... and $6.6 million, respectively, for the same periods in 2007. The increase was primarily due to ...

Isis Reports Financial Results and Highlights for Second Quarter of 2008

... $17.3 million and $35.8 million during the same periods in 2007. On a GAAP basis, Isis recorded a loss ... to $19.7 million and $40.6 million for the same periods in 2007. The significant improvement in ... higher than the revenue from the same periods in 2007 of $3.8 million and $6.3 million as ...

GeneNews Announces Second Quarter Results

... (year-to-date - $6.2 million) for the same periods last year. Research and development expenses in ... (year-to-date - $4.4 million) for the same periods last year. General and administrative expenses ... (year-to-date - $1.3) for the corresponding periods in the previous year. The net loss for the ...

SemBioSys announces second quarter 2008 financial and operational results

... Total revenue for the three and six-month periods ended June 30, 2008 was $62,207 and $272,234 ... $459,407 and $1,002,195 for the corresponding periods in 2007. The difference is due mainly to a ... Total expenditures for the three and six-month periods ended June 30, 2008 were $6,542,258 and ...

Oncolytics Biotech Inc. Announces 2008 Second Quarter Results

... highlights for the three and six month periods ended June 30, 2008. "Oncolytics experienced a ... evaluable patients experienced stable disease for periods ranging from two to more than ten, 28-day ... patients experiencing stable disease for periods ranging from two to more than twelve, 28-day ...

Beckman Coulter Announces Second Quarter 2008 Results

... the associated recurring revenue in future periods positions the company for reliable and ... to estimate the costs to be incurred in those periods and believes those costs do not reflect ... of ongoing operating results against prior periods and against our internally developed targets. We ...

Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results

... Net Sales periods Ending June 30, 2008 and 2007 ... Key Product Line Sales periods Ending June 30, 2008 and 2007 ... by US and International Three-Month periods Ending June 30, 2008 and 2007 ...

ARIUS announces second quarter fiscal 2008 financial results

... May 31, 2007. This increase in net loss for both periods is primarily the result of higher research ... same period in fiscal 2007. The increase for both periods was primarily the result of the recognition of ... same period in fiscal 2007. The decrease for both periods was primarily the result of lower average cash ...

Helix BioPharma product development update, quarterly highlights and financial results for fiscal Q3 2008

... financial results for the three and nine month periods ended April 30, 2008. "During the quarter, we ... RESULTS FROM OPERATIONS Three and nine month periods ended April 30, 2008 compared to the same period ... and $4,309,000 for the three and nine month periods ended April 30, 2008, respectively, for a loss ...

Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter

... respectively. For the comparable periods of fiscal 2007, the amounts were $2.9 million and ... million, and $49.5 million, in the comparable periods of fiscal 2007, respectively. Income tax ... per share for fiscal 2008. For the comparable periods of fiscal 2007, the amounts were a net loss of ...

Edwards Lifesciences Reports Strong First Quarter Results and Raises 2008 Guidance

... core operating results and trends for the periods presented. Non-GAAP financial measures are ... core operating results and trends for the periods presented. Non-GAAP financial measures are not ... relative to the operating results for the periods presented, these items have been excluded ...

Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook

... Net Sales periods Ending March 31, 2008 and 2007 ... Key Product Line Sales periods Ending March 31, 2008 and 2007 ... Sales by US and International periods Ending March 31, 2008 and 2007 ...

Renovis Reports Fourth Quarter and Full Year 2007 Financial Results

... million and $10.4 million in the corresponding periods in 2006. All of the revenue earned in the year ... to $7.4 million and $28.1 million during the same periods in 2006. The decrease in the fourth quarter of ... to $3.9 million and $15.6 million during the same periods of 2006. The decrease in the quarter ended ...

Helix BioPharma reports Q2 2008 highlights, financial results

... months ended January 31, 2008, compared to same periods in previous year Total revenue was negatively ... in Canada for both the three and six month periods ended January 31, 2008. Overall expenditures were ... respectively, for the three and six month periods ended January 31, 2008, for a loss per common ...

ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results

... (or $23.1 million), respectively, for the same periods in 2006. The change in gross margin for the ... to $6.1 million and $23.8 million during the same periods of 2006. The increase in research and development ... million and $37.4 million for the corresponding periods in 2006. The 2007 increase primarily resulted ...

United Therapeutics Reports Fourth Quarter and Annual 2007 Financial Results

... ended December 31, 2007, over the same periods in 2006, primarily as a result of a stock option ... 2007 and 2006, respectively. For the three-month periods ended December 31, 2007 and 2006, we recognized a ... of net income and EBITDASO for the three-month periods ended December 31, 2007 and 2006, and for ...

Favrille Reports Fourth Quarter and Year End 2007 Financial Results

... $40.5 million, or $1.49 per share, for the same periods in 2006. (Logo: ... $7.7 million and $31.1 million for the same periods in 2006. The increase is primarily due to ... $2.9 million and $11.2 million for the same periods in 2006. The decrease for the quarter ...

Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark.

... (all percentage comparisons are to comparable periods in 2006): -- Q4 2007 Sales Set New Quarterly ... diluted EPS for the quarter and year-to-date periods can be found on pages 4 and 11, respectively. -- ... (all percentage comparisons are to comparable periods in 2006): A reconciliation of reported and ...

Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History

... facilitate comparisons of results for current periods and guidance for future periods with our historical operating results, and assist ... statement for the three months and twelve months periods ending in 2007 and 2006. ...

KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis

... consolidated financial statements for the fiscal periods 2004 through 2006. Due to the pending ... period. Net revenue growth in the current year periods was due to increased volume in the Company's pain ... of the Company's financial statements for fiscal periods from 1996 through 2006 and for the quarter ended ...
Other Contents
(Date:7/27/2014)... has revealed that nicotine and cotinine, a metabolite of ... certain carcinogen in smoke. , The carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or ... and ultimately ends up in the tobacco smoke. Once ... where it is activated by a variety of enzymes ... revealed that nicotine can partially interfere with the activation ...
(Date:7/27/2014)... can evade treatment by acquiring mutations in the genes ... were once thought to be the only way for ... shown that microorganisms can use a temporary silencing of ... the benefits of drug resistance without the commitment. , ... called Mucor circinelloides, it is likely to be employed ...
(Date:7/27/2014)... patients, scientists have identified more than two dozen ... six that had not been previously reported. The ... partially funded by the National Institutes of Health ... laboratories. , "Unraveling the genetic underpinnings of Parkinson,s ... in this complex disease, and hopefully, may one ...
Breaking Biology News(10 mins):Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2Scientists discover new, noncommittal mechanism of drug resistance 2Scientists discover new, noncommittal mechanism of drug resistance 3NIH scientists find 6 new genetic risk factors for Parkinson's 2
(Date:7/29/2014)... July 29, 2014 Tucson-based company ... employer’s benefits package, or health and wellness program, called ... while providing an effective way for employees to use ... of the program, employees specify the amount of each ... , An employer benefits from offering a 401(play)™ plan ...
(Date:7/29/2014)... Guests at Napa Valley's quintessential luxury resort, ... new sleep experience. The top of each luxurious resort bed ... , These expertly crafted, 100% Egyptian cotton white duvets and ... yet upon closer look, words are woven in the linens ... breathe. , Intentional breathing and visualization are keys ...
(Date:7/29/2014)... 2014 In his latest blog post at ... CEO Per Wickstrom has listed 6 ways to light the ... creativity and avoid complacency, but for some it’s a losing ... progressive and powerful ways to help employees get to the ... as a whole.” , According to Per Wickstrom, 6 ways ...
(Date:7/29/2014)... Battle Creek, MI (PRWEB) July 29, 2014 ... treatment program that gets clients off to a great start ... believe in, was a proud sponsor of the National Cherry ... City, MI. , The concert, which was co-sponsored by Miller ... Collective Soul take to the Pepsi Bay Side Music Stage ...
(Date:7/29/2014)... 29, 2014 Launched in 2012 by ... surpassed 20,000 hangovers earlier this year at its Vegas ... expansion and the publication of research data related to ... practice. , The only licensed medical practice dedicated to ... launched in 2012 and treated thousands of patients within ...
Breaking Medicine News(10 mins):Health News:Outski launches 401(play)™ Plan to Employers as Part of an Employee Benefit / Health and Wellness Program 2Health News:Auberge Du Soleil Offers INTENTIONS™ by Peacock Alley on Guests' Beds Providing a Unique Sleep Experience 2Health News:Per Wickstrom’s Latest Blog Post Lists 6 Ways to Light the “Fire” in Employees 2Health News:A Forever Recovery Sponsors National Cherry Festival Kickoff Concert Featuring Collective Soul on July 5 in Traverse City, MI 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 3
Other TagsOther Tags